September 4, 2020
Summary of Manufacturer Communications and Verity Responses to Date
This page includes a summary of Verity responses to drug manufacturer communications to Covered Entities regarding contract pharmacy restrictions. It is updated as new information is received. Manufacturers and their respective wholesalers have taken varied approaches to the restrictions they have imposed (e.g. removal of catalog items, non-340B prices in 340B catalogs, rejected manufacturer rebates), […]